|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu DG: Epigenetic alterations in gastric
cancer (Review). Mol Med Rep. 12:3223–3230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ushijima T and Sasako M: Focus on gastric
cancer. Cancer Cell. 5:121–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: Sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tennant DA, Durán RV and Gottlieb E:
Targeting metabolic transformation for cancer therapy. Nat Rev
Cancer. 10:267–277. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rankin EB and Giaccia AJ: The role of
hypoxia-inducible factors in tumorigenesis. Cell Death Differ.
15:678–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiao S and Zhou L: Gastric cancer:
Metabolic and metabolomics perspectives (Review). Int J Oncol.
51:5–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang
Z, Zhang H, Zhao Q, Fan D and Hong L: Molecular mechanisms and
theranostic potential of miRNAs in drug resistance of gastric
cancer. Expert Opin Ther Targets. 21:1063–1075. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong SM, Xiao C, Finley LW, Lahusen T,
Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, et al:
SIRT4 has tumor-suppressive activity and regulates the cellular
metabolic response to DNA damage by inhibiting mitochondrial
glutamine metabolism. Cancer Cell. 23:450–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moffat J, Grueneberg DA, Yang X, Kim SY,
Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK,
et al: A lentiviral RNAi library for human and mouse genes applied
to an arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu
Z, Li M, Zeng M, Zhou F and Song L: Expression and cytoplasmic
localization of SAM68 is a significant and independent prognostic
marker for renal cell carcinoma. Cancer Epidemiol Biomarkers Prev.
18:2685–2693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Emerling BM, Weinberg F, Liu JL, Mak TW
and Chandel NS: PTEN regulates p300-dependent hypoxia-inducible
factor 1 transcriptional activity through Forkhead transcription
factor 3a (FOXO3a). Proc Natl Acad Sci USA. 105:2622–2627. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bell EL, Emerling BM, Ricoult SJ and
Guarente L: SirT3 suppresses hypoxia inducible factor 1α and tumor
growth by inhibiting mitochondrial ROS production. Oncogene.
30:2986–2996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Finley LW, Carracedo A, Lee J, Souza A,
Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish
CB, et al: SIRT3 opposes reprogramming of cancer cell metabolism
through HIF1α destabilization. Cancer Cell. 19:416–428. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Adler V, Yin Z, Tew KD and Ronai Z: Role
of redox potential and reactive oxygen species in stress signaling.
Oncogene. 18:6104–6111. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bell EL, Klimova TA, Eisenbart J,
Schumacker PT and Chandel NS: Mitochondrial reactive oxygen species
trigger hypoxia-inducible factor-dependent extension of the
replicative life span during hypoxia. Mol Cell Biol. 27:5737–5745.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chandel NS, McClintock DS, Feliciano CE,
Wood TM, Melendez JA, Rodriguez AM and Schumacker PT: Reactive
oxygen species generated at mitochondrial complex III stabilize
hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2
sensing. J Biol Chem. 275:25130–25138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pore N, Jiang Z, Shu HK, Bernhard E, Kao
GD and Maity A: Akt1 activation can augment hypoxia-inducible
factor-1alpha expression by increasing protein translation through
a mammalian target of rapamycin-independent pathway. Mol Cancer
Res. 4:471–479. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Minet E, Arnould T, Michel G, Roland I,
Mottet D, Raes M, Remacle J and Michiels C: ERK activation upon
hypoxia: Involvement in HIF-1 activation. FEBS Lett. 468:53–58.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cassavaugh JM, Hale SA, Wellman TL, Howe
AK, Wong C and Lounsbury KM: Negative regulation of HIF-1α by an
FBW7-mediated degradation pathway during hypoxia. J Cell Biochem.
112:3882–3890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu K, Alcivar AL, Ma J, Foo TK, Zywea S,
Mahdi A, Huo Y, Kensler TW, Gatza ML and Xia B: NRF2 induction
supporting breast cancer cell survival is enabled by oxidative
stress-induced DPP3-KEAP1 interaction. Cancer Res. 77:2881–2892.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ngo HK, Kim DH, Cha YN, Na HK and Surh YJ:
Nrf2 mutagenic activation drives hepatocarcinogenesis. Cancer Res.
77:4797–4808. 2017.PubMed/NCBI
|
|
28
|
Abu-Alainin W, Gana T, Liloglou T,
Olayanju A, Barrera LN, Ferguson R, Campbell F, Andrews T, Goldring
C, Kitteringham N, et al: UHRF1 regulation of the Keap1-Nrf2
pathway in pancreatic cancer contributes to oncogenesis. J Pathol.
238:423–433. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hayes AJ, Skouras C, Haugk B and Charnley
RM: Keap1-Nrf2 signalling in pancreatic cancer. Int J Biochem Cell
Biol. 65:288–299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sporn MB and Liby KT: NRF2 and cancer: The
good, the bad and the importance of context. Nat Rev Cancer.
12:564–571. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cardone RA, Casavola V and Reshkin SJ: The
role of disturbed pH dynamics and the Na+/H+
exchanger in metastasis. Nat Rev Cancer. 5:786–795. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kato Y, Lambert CA, Colige AC, Mineur P,
Noël A, Frankenne F, Foidart JM, Baba M, Hata R, Miyazaki K and
Tsukuda M: Acidic extracellular pH induces matrix
metalloproteinase-9 expression in mouse metastatic melanoma cells
through the phospholipase D-mitogen-activated protein kinase
signaling. J Biol Chem. 280:10938–10944. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu P, Takai K, Weaver VM and Werb Z:
Extracellular matrix degradation and remodeling in development and
disease. Cold Spring Harb Perspect Biol. 3:a0050582011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu J, Li J, Chen Y, Cao W, Lu Y, Yang J
and Xing E: Snail enhances glycolysis in the epithelial-mesenchymal
transition process by targeting FBP1 in gastric cancer. Cell
Physiol Biochem. 43:31–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang MH, Wu MZ, Chiou SH, Chen PM, Chang
SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by
HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arany Z, Foo SY, Ma Y, Ruas JL,
Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J,
Rangwala SM, et al: HIF-independent regulation of VEGF and
angiogenesis by the transcriptional coactivator PGC-1alpha. Nature.
451:1008–1012. 2008. View Article : Google Scholar : PubMed/NCBI
|
